OBJECTIVES: Chronic pancreatitis (CP) results in an extremely poor quality of life and substantially increases health care utilization. Few data exist regarding the cost-effectiveness of surgical treatment for CP. METHODS: This article examined the cost-effectiveness of total pancreatectomy (TP) with islet cell autotransplantation (IAT) for CP. RESULTS: Sixty patients undergoing TP + IAT and 37 patients undergoing TP were identified. Surgery resulted in significant reduction in opiate use, frequency of hospital admissions, and length of stay as well as visual analog scale scores for pain. Total pancreatectomy + IAT resulted in longer survival than TP alone (16.6 vs 12.9 years); 21.6% of patients with TP + IAT were insulin-independent, and those requiring insulin have reduced daily requirements compared with those having TP alone (22 vs 35 IU). The cost of TP + IAT with attendant admission and analgesia costs over the 16-year survival period was £110,445 compared with £101,608 estimated 16-year costs if no TP + IAT was undertaken. CONCLUSIONS: Total pancreatectomy + IAT is effective in improving pain and reducing analgesia. Islet cell transplantation offers the chance of insulin independence and results in lower insulin requirements, as well as conferring a survival advantage when compared with TP alone. Total pancreatectomy + IAT is cost-neutral when compared with nonsurgical or segmental surgical therapy.
OBJECTIVES:Chronic pancreatitis (CP) results in an extremely poor quality of life and substantially increases health care utilization. Few data exist regarding the cost-effectiveness of surgical treatment for CP. METHODS: This article examined the cost-effectiveness of total pancreatectomy (TP) with islet cell autotransplantation (IAT) for CP. RESULTS: Sixty patients undergoing TP + IAT and 37 patients undergoing TP were identified. Surgery resulted in significant reduction in opiate use, frequency of hospital admissions, and length of stay as well as visual analog scale scores for pain. Total pancreatectomy + IAT resulted in longer survival than TP alone (16.6 vs 12.9 years); 21.6% of patients with TP + IAT were insulin-independent, and those requiring insulin have reduced daily requirements compared with those having TP alone (22 vs 35 IU). The cost of TP + IAT with attendant admission and analgesia costs over the 16-year survival period was £110,445 compared with £101,608 estimated 16-year costs if no TP + IAT was undertaken. CONCLUSIONS: Total pancreatectomy + IAT is effective in improving pain and reducing analgesia. Islet cell transplantation offers the chance of insulin independence and results in lower insulin requirements, as well as conferring a survival advantage when compared with TP alone. Total pancreatectomy + IAT is cost-neutral when compared with nonsurgical or segmental surgical therapy.
Authors: Gregory C Wilson; Syed A Ahmad; Daniel P Schauer; Mark H Eckman; Daniel E Abbott Journal: J Gastrointest Surg Date: 2014-08-06 Impact factor: 3.452
Authors: Melena D Bellin; Andres Gelrud; Guillermo Arreaza-Rubin; Ty B Dunn; Abhinav Humar; Katherine A Morgan; Bashoo Naziruddin; Cristiana Rastellini; Michael R Rickels; Sarah J Schwarzenberg; Dana K Andersen Journal: Pancreas Date: 2014-11 Impact factor: 3.327
Authors: Melena D Bellin; Tossapol Kerdsirichairat; Gregory J Beilman; Ty B Dunn; Srinath Chinnakotla; Timothy L Pruett; David R Radosevich; Sarah J Schwarzenberg; David E R Sutherland; Mustafa A Arain; Martin L Freeman Journal: Clin Gastroenterol Hepatol Date: 2016-03-08 Impact factor: 11.382
Authors: Samuel J Kesseli; Matthew Wagar; Min K Jung; Kerrington D Smith; Yu Kuei Lin; R Matthew Walsh; Betul Hatipoglu; Martin L Freeman; Timothy L Pruett; Gregory J Beilman; David E R Sutherland; Ty B Dunn; David A Axelrod; Sushela S Chaidarun; Tyler K Stevens; Melena Bellin; Timothy B Gardner Journal: Am J Gastroenterol Date: 2017-02-07 Impact factor: 10.864
Authors: Luis F Lara; Melena D Bellin; Emmanuel Ugbarugba; Jaimie D Nathan; Piotr Witkowski; Martin Wijkstrom; Jennifer L Steel; Kerrington D Smith; Vikesh K Singh; Sarah J Schwarzenberg; Timothy L Pruett; Bashoo Naziruddin; Leslie Long-Simpson; Varvara A Kirchner; Timothy B Gardner; Martin L Freeman; Ty B Dunn; Srinath Chinnakotla; Gregory J Beilman; David B Adams; Katherine A Morgan; Maisam A Abu-El-Haija; Syed Ahmad; Andrew M Posselt; Michael G Hughes; Darwin L Conwell Journal: Pancreas Date: 2019-10 Impact factor: 3.327
Authors: Melena D Bellin; Martin L Freeman; Andres Gelrud; Adam Slivka; Alfred Clavel; Abhinav Humar; Sarah J Schwarzenberg; Mark E Lowe; Michael R Rickels; David C Whitcomb; Jeffrey B Matthews; Stephen Amann; Dana K Andersen; Michelle A Anderson; John Baillie; Geoffrey Block; Randall Brand; Suresh Chari; Marie Cook; Gregory A Cote; Ty Dunn; Luca Frulloni; Julia B Greer; Michael A Hollingsworth; Kyung Mo Kim; Alexander Larson; Markus M Lerch; Tom Lin; Thiruvengadam Muniraj; R Paul Robertson; Seth Sclair; Shalinender Singh; Rachelle Stopczynski; Frederico G S Toledo; Charles Melbern Wilcox; John Windsor; Dhiraj Yadav Journal: Pancreatology Date: 2013-11-13 Impact factor: 3.996
Authors: Joshua S Jolissaint; Linda W Langman; Claire L DeBolt; Jacob A Tatum; Allison N Martin; Andrew Y Wang; Daniel S Strand; Victor M Zaydfudim; Reid B Adams; Kenneth L Brayman Journal: Clin Transplant Date: 2016-10-17 Impact factor: 2.863
Authors: Varvara A Kirchner; Ty B Dunn; Gregory J Beilman; Srinath Chinnakotla; Timothy L Pruett; Joshua J Wilhelm; Sarah J Schwarzenberg; Martin L Freeman; Melena D Bellin Journal: Curr Treat Options Gastroenterol Date: 2017-12